Valuation (12%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -7.06 | N/A |
| PEG Ratio (TTM) | -0.31 | N/A |
| P/S Ratio (TTM) | 363.69 | N/A |
| P/B Ratio (TTM) | 1.83 | N/A |
| P/FCF Ratio (TTM) | -5.82 | N/A |
| Price to 5YR AVG Earnings Ratio | -4.96 | N/A |
| Price to 5YR AVG FCF Ratio | -6.46 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -24.53% | N/A |
| ROE (TTM) | -24.02% | N/A |
| Net Profit Margin (TTM) | -5,196.89% | N/A |
| ROIC 5YR AVG | -36.42% | N/A |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 19.38% | -48.41% | -35.24% |
| Revenue | -25.00% | N/A | 176.98% |
| Net Income | 19.40% | -981,444.71% | -588,874.31% |
| Cash Flow | 20.73% | -106.46% | -72.93% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 17.62 | N/A |
| Quick Ratio (TTM) | 17.62 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | -31,956.50 | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | 18.56 | N/A |
| LTL to 5YR AVG FCF | -0.09 | N/A |
| Shares Outstanding Growth 5YR AVG | 59.77% | N/A |